Fidelity Investments’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Fidelity Investments’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29	Closed	-$426	–	5515
2025 Q4	$426	Buy	+29	New	+$464	﹤0.01%	5168
2025 Q1	–	Hold	0	–	-$5	–	5550
2024 Q4	–	Hold	0	–	–	–	5484
2024 Q3	–	Hold	0	–	-$15	–	5656
2024 Q2	–	Hold	0	–	–	–	5242

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

MCA

McGuire Capital Advisors Bethany, Oklahoma $156M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

GSEP

Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's MRNY Position: Q1 2026 in Review

Fidelity Investments sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 29 shares — an estimated $426 sold.

Fidelity Investments first reported a position in MRNY in Q4 2025 and held it in 1 quarter. The position peaked at $426 in Q4 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

Fidelity Investments reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
Fidelity Investments sold 29 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $426.
Fidelity Investments first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2025 and held it in 1 quarter.
Fidelity Investments's YieldMax MRNA Option Income Strategy ETF position peaked at $426 in Q4 2025.
11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.